Array Technologies, Inc. (NASDAQ: ARRY) is a Energy company in the Solar industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
4.24
+0.04+0.95%
News
Up 1.0% — Why Array Technologies, Inc. (ARRY) Dipped More Than Broader Market Today (zacks.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | - | P/E | - | EPS (ttm) | -0.98 | Insider Own | - | Shs Outstand | 153.83M | Perf Week | -6.81% |
| Market Cap | 652.22M | Forward P/E | 4.76 | EPS next Y | 0.89 | Insider Trans | 0.00% | Shs Float | 139.88M | Perf Month | -11.67% |
| Enterprise Value | 1.09B | PEG | - | EPS next Q | 0.11 | Inst Own | - | Short Float | 25.34% | Perf Quarter | -44.65% |
| Income | -86.00M | P/S | 0.55 | EPS this Y | 176.68% | Inst Trans | - | Short Ratio | 5.25 | Perf Half Y | -38.19% |
| Sales | 1.18B | P/B | 2.20 | EPS next Y | 18.62% | ROA | -5.60% | Short Interest | 35.45M | Perf YTD | -54.01% |
| Book/sh | 1.92 | P/C | 2.12 | EPS next 5Y | -0.26% | ROE | -47.02% | 52W High | 12.23 -65.33% | Perf Year | -45.15% |
| Cash/sh | 2.00 | P/FCF | 5.27 | EPS past 3/5Y | - | ROIC | 3.47% | 52W Low | 4.11 3.16% | Perf 3Y | -83.14% |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | -7.80% 8.02% | Gross Margin | 24.27% | Volatility | 4.17% 4.63% | Perf 5Y | -77.51% |
| Dividend TTM | - | EV/Sales | 0.92 | EPS Y/Y TTM | 49.74% | Oper. Margin | 3.32% | ATR (14) | 0.26 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.81 | Sales Y/Y TTM | 29.26% | Profit Margin | -7.25% | RSI (14) | 35.16 | Recom | 2.54 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.20 | EPS Q/Q | -4.00% | SMA20 | -6.36% | Beta | 1.82 | Target Price | 8.42 |
| Payout | 0.00% | Debt/Eq | 2.92 | Sales Q/Q | -5.52% | SMA50 | -17.80% | Rel Volume | 0.67 | Prev Close | 4.20 |
| Employees | 1,200 | LT Debt/Eq | 2.88 | Earnings | Nov 04 | SMA200 | -45.11% | Avg Volume | 6.49M | Price | 4.24 |
| IPO Date | Oct 15, 2020 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 97.22% 9.30% | Net Debt/EBITDA | 107.01 | Volume | 4,354,189 | Change | 0.95% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-08-26 | Initiated | Piper Sandler | Neutral | $8.00 → $5.00 |
| Aug-06-26 | Reiterated | Robert W. Baird | $10 → $9.00 | |
| Aug-06-26 | Reiterated | Deutsche Bank | Hold | $8.90 → $7.50 |
| Aug-06-26 | Reiterated | Wolfe Research | Outperform | $9.00 |
| Aug-06-26 | Reiterated | UBS | Buy | $11 → $10 |
| Jul-21-26 | Downgrade | JP Morgan | Overweight → Neutral | |
| Jul-17-26 | Reiterated | Roth Capital | Neutral | $9.00 → $6.00 |
| Jul-10-26 | Reiterated | Susquehanna | Neutral | $8.00 → $7.25 |
| Jul-02-26 | Reiterated | Jefferies | Buy | $8.00 → $10 |
| May-07-26 | Reiterated | Goldman Sachs | Buy | $11 → $12 |
Latest News· Times ET
Sep-16-26
Sep-10-26
Sep-10-2603:16PM
Sep-09-26
Sep-09-2602:08PM
Sep-04-26
Sep-04-2602:32PM
Sep-02-26
Sep-02-2604:01AM
Sep-01-26
Sep-01-2603:41PM
Aug-31-26
Aug-31-2612:05PM
Aug-27-26
Aug-20-26
Aug-20-2610:33PM
03:01PM
03:00AM
Aug-19-26
Aug-12-26
Aug-11-26
Company
Array Technologies, Inc. (ARRY) develops, manufactures, and provides solar tracking solutions and complementary products for customers both within the United States and internationally. A key offering is the DuraTrack HZ v3, a system designed for single-axis solar panel tracking. Additionally, the company offers SmarTrack, an intelligent software powered by machine learning that continuously determines the optimal alignment for solar arrays in real time to maximize energy output. This enterprise was established in 1989 and its corporate headquarters are situated in Albuquerque, New Mexico.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,184 | 1,284 | 916 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 897 | 986 | 618 | — | — | — | — | — | — | |
| Gross Profit | 288 | 299 | 298 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 213 | 199 | 161 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 35 | 26 | 364 | — | — | — | — | — | — | |
| Operating Income | 40 | 74 | -227 | — | — | — | — | — | — | |
| Interest Expense | 22 | 27 | 35 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -91 | -76 | 11 | — | — | — | — | — | — | |
| Net Income Before Taxes | -74 | -29 | -251 | — | — | — | — | — | — | |
| Income Taxes | 12 | 23 | -10 | — | — | — | — | — | — | |
| Consolidated Net Income | -86 | -52 | -240 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -86 | -52 | -240 | — | — | — | — | — | — | |
| Net Income | -86 | -52 | -240 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.98 | -0.73 | -1.95 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.98 | -0.73 | -1.95 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.98 | -0.73 | -1.95 | — | — | — | — | — | — | |
| EBITDA | 4 | 45 | -163 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.55 | 1.10 | 1.00 | — | — | — | — | — | — | |
| Gross Margin | 24.32 | 23.29 | 32.53 | — | — | — | — | — | — | |
| Operating Margin | 3.38 | 5.76 | -24.78 | — | — | — | — | — | — | |
| Net Margin | -7.26 | -4.05 | -26.20 | — | — | — | — | — | — | |
| Shares Outstanding | 154 | 153 | 152 | — | — | — | — | — | — | |
| Market Capitalization | 653 | 1,411 | 918 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Iyengar Jayanthi | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 73,807 | May 21 |
| Forth John Bradford | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 151,020 | May 21 |
| ASHFORD ORLANDO D | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 74,333 | May 21 |
| Alstead Troy | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 74,333 | May 21 |
| Jokinen Tracy C | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 44,516 | May 21 |
| Schmid Gerrard | Director | May 19 '26 | Option Exercise | 0.00 | 22,164 | 0 | 85,785 | May 21 |
| Hostetler Kevin G. | Chief Executive Officer | Mar 18 '26 | Option Exercise | 0.00 | 125,067 | 0 | 376,607 | Mar 19 |
| Manning Neil | President & COO | Mar 18 '26 | Option Exercise | 0.00 | 20,391 | 0 | 59,400 | Mar 19 |
| Zhu James | Chief Accounting Officer | Mar 18 '26 | Option Exercise | 0.00 | 12,234 | 0 | 20,922 | Mar 19 |
| Gunning Gina K | Chief Legal Officer | Mar 18 '26 | Option Exercise | 0.00 | 21,886 | 0 | 30,543 | Mar 19 |
| Collins Terrance L | Chief Human Resources Officer | Mar 18 '26 | Option Exercise | 0.00 | 20,391 | 0 | 69,095 | Mar 19 |
| Jennings H. Keith | Chief Financial Officer | Mar 18 '26 | Option Exercise | 0.00 | 40,782 | 0 | 40,782 | Mar 19 |
| Collins Terrance L | Chief Human Resources Officer | Mar 17 '26 | Option Exercise | 0.00 | 6,152 | 0 | 50,387 | Mar 19 |
| Manning Neil | President & COO | Mar 17 '26 | Option Exercise | 0.00 | 4,882 | 0 | 40,320 | Mar 19 |
| Hostetler Kevin G. | Chief Executive Officer | Mar 17 '26 | Option Exercise | 0.00 | 35,150 | 0 | 266,251 | Mar 19 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.